US regulators give go-ahead for muscle wasting treatment costing $3mn 0 21.06.2024 01:22 Financial Times Shares of biotech Sarepta soar 40% after approval for most expensive treatment in the world Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
